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Outcome of Involuntary Medication
in a State Hospital System
Francine Cournos, M.D., Karen McKinnon, M.A., and Barbara Stanley, Ph.D.
Objective: The purpose of the study was to examine the course of involuntarily admin-
istered medication in a state hospital population. Method: The authors retrospectively ex-
amined the records of all 51 involuntarily medicated patients in six state hospitals in New
York City in a single calendar year. Clinical course was recorded for the period of involun-
tary medication and for 12 months thereafter. These patients were compared to 51 patients
on the same wards who accepted medication. Results: Clinicians assessed involuntarily
medicated patients as more dangerous to themselves or others and less delusional after
treatment than the comparison patients. Long-acting intramuscular antipsychotics were pre-
scribed more frequently for involuntarily medicated patients. No differences were observed
in rates of discharge, outpatient cooperation, or rehospitalization. Half of the patients in
both groups remained continuously institutionalized, and of those who left the hospital, only
30% of the involuntarily medicated group and 40% of the comparison group took medi-
cation as outpatients. Conclusions: For these chronically severely ill patients, involuntary
medication did not appear to enhance insight or cooperation or result in rapid return to the
community. Involuntary medication is often a necessary short-term, in-hospital management
strategy, but it does not replace the need to develop comprehensive, long-term inpatient and
community-based approaches to the management of treatment refusal.
(AmJ Psychiatry 1991; 148:489-494)
A lthough the right of committed patients to refuse
medication has now been asserted for a decade
(1), we know little about what happens after a course
of involuntary treatment (2). The rationale for invol-
untary medication is that it is in the best interest of the
patient, will improve the patient’s contact with reality
and diminish dangerousness to self and others, will
help the patient acknowledge the need for continued
treatment, and will ultimately yield better treatment
compliance. Most studies of involuntary medication
focus on patients’ reasons for refusing medication. Re-
fusal may be based on the patient’s illness, such as
psychotic ideas about medication or denial of illness
(2-7); legitimate complaints about the treatment itself,
including severe side effects or lack of efficacy (3, 8); or
the patient’s personality, such as the desire to maintain
control (2, 5). However, studies have not examined
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whether our assumptions about the long-term effects
of involuntary medication are valid.
While involuntarily medicated patients may later cx-
press positive feelings about their treatment (6, 9), the
frequency with which such patients continue to take
medication after discharge is not known. Previous out-
come studies have been rare and long-term follow-up
has been neglected. In a small-scale study involving 10
state hospital patients, patients who refused medica-
tion remained hospitalized longer and were rehospital-
ized sooner than those who consented (5). Medication
compliance after discharge did not appear to differ
from that of matched control subjects.
Most of the landmark legal decisions about invol-
untary treatment grew out of cases in state hospitals
(1, 10). For this reason it is important to study the
outcome of involuntary medication among patients in
this setting.
This retrospective study examined the inpatient and
outpatient histories of a group of state hospital pa-
tients who had completed a course of involuntary mcd-
ication and compared their outcomes to those of a
group of matched patients who complied with mcdi-
cation in the hospital. We sought to determine whether
involuntarily medicated patients would be 1) less likely
to leave the hospital within the study period or have
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TABLE 1. Demographic and Clinical Characteristics of lnvolun-




Item N % N %
Sex
Men 31 60.8 31 60.8
Women 20 39.2 20 39.2
Ethnic group
Black 22 43.1 26 S1.0
White 22 43.1 15 29.4
Hispanic 6 11.8 10 19.6
Asian 1 2.0 0 0.0
Graduated from high school 26 51.0 23 45.1
Never married 30 58.8 25 49.0
Admission diagnosis
Schizophrenia 36 70.6 26 51.0
Schizoaffective disorder 2 3.9 5 9.8
Affective disorder 2 3.9 3 5.9
Organic disorder or
dementia 2 3.9 2 3.9
Other psychiatric disorder 9 17.6 14 27.5
Unknown 0 0.0 1 2.0
Psychotic symptoms reported
on admission
Thought disorder 4 7.9 7 13.8
Hallucinations 8 15.7 11 21.6
Delusions 25 49.0 21 41.2
Primary clinical indication for
treatment
Dangerous to self or othersa 45 88.2 37 72.5
Inadequate self-care,
regressed 18 35.3 24 47.1
Dangerous to others 15 29.4 11 21.6
Worsening medical condi-
tion because of inabil-
ity to care for self 10 19.6 1 2.0
Suicidal 2 3.9 1 2.0
Severe mental illness, not
dangerous 6 11.8 14 27.5
asignificant difference between groups (24.OO, df=1, p<O.OOl).
significantly longer lengths of stay in the hospital, 2)
more likely to refuse other inpatient care such as food,
personal hygiene, and medical treatment in addition to
psychiatric medication, 3) less likely to comply with
outpatient treatment after discharge, and 4) more
likely to be rehospitalized during the follow-up period.
METHOD
We examined the treatment histories of patients in-
voluntarily hospitalized and medicated in the six state
hospitals for adults in New York City, comprising ap-
proximately 4,300 beds. Inpatient and outpatient
records of all S 1 patients who received administcative
approval for involuntary medication during the 12-
month period from Jan. 1 to Dec. 31, 1985, were re-
viewed. Fifty-one patients matched for hospital ward
and legal status at the time of the index patients’ first
clinical evaluation for involuntary medication were Sc-
lccted as a comparison group. Ward was selected as a
matching variable in order to control for effects of staff
attitudes toward the use of involuntary medication.
Legal status was selected to control for severity of ill-
ness, since the literature indicates that involuntary pa-
tients may be more severely ill than voluntary patients
(1 1-13). Records from admission through the 12
months after termination of the index patients’ invol-
untary treatment approval period were reviewed for
both patient groups. At the time of the first evaluation
for involuntary medication, 40 (78.4%) of the index
patients had civil commitment status, six (11.8%) had
criminal commitment status, and five (9.8%) were vol-
untary. Matched patients had identical legal status at
the time of the first evaluation. However, the few vol-
untary index patients were converted to involuntary
status, as required by New York State regulations, be-
fore the final involuntary medication approval was
given.
Legal status on admission was only slightly different
in the two groups. Thirty-seven (72.5%) involuntarily
medicated patients had civil commitment status, and
10 (19.6%) had criminal commitment status; only
four (7.8%) were voluntarily admitted. Among the
comparison group, 35 (68.6%) had civil commitment
status, six (11.8%) had criminal status, and seven
(13.7%) were voluntarily admitted. Three (5.9%) of
the matched patients had unknown legal status on ad-
mission. Thus, to the extent that involuntary admis-
sion correlates with greaten severity of illness, the
two patient groups were not significantly different on
admission.
Data were collected by reviewing all documents gen-
crated by the involuntary treatment procedure, includ-
ing clinical evaluations and final outcome reports, and
patients’ charts. For the comparison group, all data
were obtained from patients’ charts. In-hospital mcd-
ication compliance was measured by reviewing nursing
records, which documented the medications ordered
and the frequency with which patients accepted them.
Outpatient compliance was determined by review of
outpatient charts. All inpatient data were derived from
New York State hospital records. Chart reviews were
supplemented with data from the State Office of Men-
tal Health’s computerized patient information system.
The fourth and final judgment regarding involuntary
medication for all state hospital patients in New York
City in 1985 was made by a physician under the din-
ical administrative review procedure used at that time
in New York State. The review procedure and subse-
quent changes have been described elsewhere (14).
RESULTS
Fifty-two applications for involuntary medication
were made during 1985. This represents 0.37% of the
total number of patients in treatment in New York
City’s adult state hospitals during the 1-year period.
One patient’s objection to involuntary medication was
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Inpatient antipsychotic medications (N=68) 17.18 1 <0.0001
Intramuscular depot antipsychotic 28 27.5 24 47.1 4 7.9
Oral antipsychotic 40 39.2 14 27.5 26 51.0
Inpatient medication noncompliance
3 months before index patient’s involuntary
medication (N=92) 35.12 2 <0.0001
>90% 24 23.5 23 45.1 1 2.0
Intermittent 15 14.7 11 21.6 4 7.8
<10% 53 52.0 14 27.5 39 76.5
Period for which index patient’s involuntary
treatment was approved (N=87) 18.OOa 2 0.000 1
>90% 8 7.8 7 13.7 1 2.0
Intermittent 19 18.6 17 33.3 2 3.9
<10% 60 58.8 24 47.1 36 70.6
Hospitalization within the 12 months after end
of index patient’s treatment approval period
(N=76) 14.29k’ 2 0.0008
>90% 7 6.9 7 13.7 0 0.0
Intermittent 12 1 1.8 10 19.6 2 3.9
<10% 57 55.9 23 45.1 34 66.7
Noncompliance with other inpatient care
Refused bathing/other self-care (N101) 37 36.3 19 37.3 18 35.3 0.02 1 0.90
Refused to eat (N=101) 24 23.5 16 31.4 8 15.7 3.29 1 0.07
Refused medical evaluation/treatment (N=100) 47 46.1 30 58.8 17 33.3 5.84 1 0.02
Improvement in delusions with antipsychotics
(N=32) 2.34a 1 0.13
Intramuscular depot antipsychotic 17 16.7 16 31.4 1 2.0
Oral antipsychotic 15 14.7 10 19.6 S 9.8
ayates correction for continuity.
upheld. Thus, Si patients (98%) received adminis-
trative approval for involuntary medication. Thirty
(58.8%) patients received approval for 3 months, nine
(17.6%) for 6 months, five (9.8%) for 9 months, four
(7.8%) for 12 months, and three (5.9%) for more than
1 year.
The S 1 matched patients were compared with the Si
patients who were involuntarily medicated. The pa-
tient groups were not significantly different on any de-
mographic variable. The mean±SD ages of the index
and comparison groups were 46.5± iS.7 and 44.5±
16.0 years. Furthermore, the clinical profiles of the
index and comparison groups were similar in terms of
known admission diagnosis, psychotic symptoms, and
number of previous total (5.0±4.7 versus 5.1±5.1)
and involuntary (2.0±2.i versus 2.5±4.6) psychiatric
hospitalizations. However, involuntarily medicated
patients were more frequently reported by clinicians as
being dangerous to themselves or others than were the
matched patients (table 1).
Not surprisingly, despite similar diagnoses, the pa-
tient groups differed significantly in the frequency with
which they were given depot intramuscular versus oral
antipsychotic medication (table 2).
Although intermittent medication refusal was ob-
served in both groups, persistent refusal, as expected,
was significantly more common among the involun-
tarily medicated group than the comparison group.
Persistent refusal was defined as a rate of more than
90% noncompliance with prescribed medications in a
given period.
Although differences on other measures of compli-
ance failed to reach significance, there appeared to be
a tendency among patients who refused medication to
be more reluctant to accept other forms of patient care,
particularly food. No differences were observed in the
number of occasions of restraint or seclusion.
Of the four involuntarily medicated patients with
documented thought disorder on admission, two
showed improvement in that symptom at the end of
the involuntary medication period. Of the seven
matched patients with documented thought disorder,
two were reported improved. Of the eight involun-
tarily medicated patients with documented hallucina-
tions, five had improvement in that symptom, while
five of the 1 1 matched patients with documented hal-
lucinations on admission were reported improved.
These differences were not statistically significant. Of
the 25 involuntarily medicated patients with docu-
mented delusions on admission, 15 (60.0%) were less
delusional, while only five (23.8%) of the 2i matched
patients with documented delusions on admission
were reported improved. This difference was statisti-
cally significant (2=6.09, df=1, p<O.O2). This differ-
ence was not explained by intramuscular versus oral
antipsychotic medication.
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TABLE 3. 12-Month Outcome of Involuntarily Medicated and Comparison Patients
All Subjects Rehospitali zed Subjects
Index Comparison Index Comparison
(N=S1) (N=S1) (N=7) (N=8)
Outcome N % N % N % N %
Continuously institutionalized 24 47.1 27 52.9
Hospital 21 41.2 23 45.1
Nursing home 3 5.9 4 7.9
Died because of medical illness while
inpatient 2 3.9 0 0.0 0 0.0 0 0.0
Discharged, follow-up available 23 45.1 20 39.2 6 85.7 8 100.0
Eloped without outpatient plan 4 7.8 5 9.8 1 14.3 1 12.5
Refused outpatient referral 4 7.8 1 2.0 2 28.6 0 0.0
Refused outpatient referral, died by
suicide 1 2.0 0 0.0 0 0.0 0 0.0
Never attended clinic 4 7.8 4 7.8 1 14.3 2 25.0
1 or 2 clinic visits only 2 3.9 2 3.9 1 14.3 1 12.5
Complied with visits but not medication 1 2.0 0 0.0 0 0.0 0 0.0
Complied with visits and medication 7 13.7 8 15.7 1 14.3 4 50.0
Discharged, no follow-up 2 3.9 4 7.8 1 14.3 0 0.0
Outpatient records unavailable 1 2.0 4 7.8 1 14.3 0 0.0
No outpatient medication prescribed;
patient to seek substance abuse
treatment 1 2.0 0 0.0 0 0.0 0 0.0
The median length of stay for the overall hospital
population was 52 days. The involuntary groups we
examined had considerably longer stays. Involuntarily
medicated patients had a mean±SD hospital stay of
35.7±43.1 months. Matched patients had a mean stay
of 66.5±123.8 months. Although there was a large
between-group difference, it was not statistically sig-
nificant because of the large standard deviations.
Table 3 summarizes rates of attendance at outpa-
tient facilities after discharge, medication compliance,
and rehospitalization for both patient groups. There
were no significant differences in postdischarge out-
come between those who were involuntarily medicated
and those who accepted medication voluntarily.
After 12 months, approximately one-half (N=24,
47. 1 %) of the involuntarily medicated patients re-
mained institutionalized. When the two patients for
whom follow-up was not relevant or available (one
was not prescribed medication, one had no available
records) were excluded, only seven (30.4%) of the 23
involuntarily medicated patients who left the hospital
complied with clinic visits and accepted medication.
After 12 months, 27 (52.9%) of the matched patients
were still institutionalized. Of 20 who left the hospital
and for whom follow-up was available, only eight
(40%) complied with clinic visits and medication.
Rehospitalization rates were derived from the New
York State hospital inpatient database and records.
Non-state-hospital records could not be obtained. One
involuntarily medicated patient was rehospitalized af-
ter 9.7 months despite compliance with outpatient
medication. Four outpatient, medication-compliant
matched patients were rehospitalized after a mean of
11.9±4.6 months. These rates were not statistically
significant.
DISCUSSION
The large state hospital system in New York City
appears to reserve the use of involuntary medication
for the patients who most persistently refuse medica-
tion and who are also considered dangerous to them-
selves on others. Although the median length of stay
for all state hospital patients was 52 days, the average
patient approved for involuntary medication had al-
ready been in the hospital for 17.5 months. Compar-
ison patients also had long stays because they were
selected from the same wards as the patients who had
refused medication, and, generally speaking, these
were units designated for long-term care rather than
for newly admitted patients. Patients for whom formal
petitions for involuntary medication were made may
have exhausted most other treatment options.
This study, then, compared two groups of long-stay
involuntary patients: those who refused both hospital-
ization and medication and those who refused hospi-
talization but, once institutionalized, complied with
medication. Involuntarily medicated patients were re-
ported to be significantly less delusional than matched
patients at the end of the involuntary treatment period.
This difference was not explained by greaten use of
depot medications. This benefit must be interpreted
with caution. The difference in improvement rates may
be biased, since extensions of involuntary medication
were granted on the basis of clinicians’ progress re-
ports. Furthermore, while delusions were reportedly
ameliorated after a course of involuntary medication,
improvement had no impact on long-term outcome.
A course of involuntary medication did not appear
to have either a negative or a positive effect on long-
term outcome. We did not find significant differences
in hospital course or outpatient compliance between
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the two patient groups. Whether or not they complied
with in-hospital medication, 60%-70% of patients
were resistant to continuing treatment after discharge.
This study could have underestimated treatment
compliance, since patients who left the hospital with-
out consent and never reentered the state system may
have sought treatment elsewhere. However, it is more
likely that the number of patients discontinuing treat-
ment is an underestimate, since outpatient medication
compliance records were based on patient self-reports.
Our results are consistent with previous findings of a
long-term unwillingness among committed patients to
engage in follow-up services (12). Patients’ resistance
was also reflected in refusal of food, self-care of per-
sonal hygiene, and medical treatment while in the hos-
pital, which occurred among patients who accepted
psychotropic medication as well as those who rejected
it.
Involuntarily medicated patients were more likely to
persistently refuse medication as inpatients and to re-
ceive treatment with long-acting, intramuscular anti-
psychotic drugs. Psychiatrists appear to prescribe long-
acting antipsychotics to avoid continuous confrontation
between the patient and the nursing staff or to ensure
that the patient does not evade the medication in pill
form. This desire to be certain that patients receive
medication may follow from the apparently dire status
of the illness presented to clinicians; 88.2% of invol-
untanily medicated patients were dangerous to them-
selves or others. This is consistent with the evidence
that of patients who refuse medication, those who
reach the formal review process are more severely ill
than are those who can eventually be persuaded by
clinicians to accept medication and those discharged
without receiving a course of medication (15).
With the severely ill population studied, involuntary
medication appeared to be a necessary management
tool for in-hospital care (14); but for most, it did not
result in rapid return to the community or later com-
pliance with medication. For many long-stay chronic
patients, a course of involuntary medication in the hos-
pital appears to be a short-term strategy that does not
produce the insight and cooperation that psychiatrists
hope to achieve.
Although some investigators have found that com-
mitted patients later accept voluntary hospitalization
(16, 17) and that involuntarily medicated patients later
express agreement with the need for treatment (9),
those studies were performed in general hospital set-
tings with less chronic patients and did not examine
medication compliance. Our study was conducted in
state hospitals with a chronic mentally ill population.
Among the chronic mentally ill, treatment refusal may
be associated with severe illness incompatible with
rapid discharge, and even when discharge is possible,
may be associated with persistent refusal despite im-
provement with medication. The patients we studied
had numerous previous psychiatric hospitalizations,
many of which were involuntary. Medication refusal
may reflect a well-entrenched pattern of resistance to
treatment. In that case the results of this study suggest
that it may be counterproductive to wait to intervene
only when refusal is persistent and the patient is chron-
ically ill and that earlier intervention may be more
successful. Alternatively, these patients may have a
more severe form of illness (15) that might affect their
appreciation of the need for treatment even if there is
symptom improvement with medication.
Our findings suggest that it may be important to
consider alternatives for the long-term management of
patients who refuse treatment. When treatment refusal
has become a chronic pattern, those in need of contin-
ued care could be considered for an expanded use of
outpatient commitment (18-20). However, not all pa-
tients who refuse treatment arc appropriate for aggres-
sive intervention in or out of the hospital, either be-
cause they are competent to reject care or can function
adequately, if not optimally, even without treatment or
because the treatment does not produce sufficiently ben-
eficial therapeutic results. For these patients we need to
consider more successful strategies of engagement includ-
ing provision of sanctuary without treatment in the com-
munity. Sanctuary could provide shelter and food while
clinicians work to encourage patients to accept mental
health services.
While we obtained 12-month follow-up data on 50
(98%) of Si patients who had completed a course of
involuntary medication in a state hospital and on 47
(92%) of 51 matched comparison subjects, this study
was retrospective in nature and thus limited in terms of
the factors that could be explored and the ability to
make causal inferences. We examined only committed
patients whose stays were far longer than the typical
state hospital patient’s. In addition, we did not exam-
inc routine refusals that were allowed by staff; our
system reserves involuntary medication for chronic,
persistent refusal within a population so severely and
chronically ill that they may be least likely to respond
to the intervention. We urge the prospective examina-
tion in both inpatient and outpatient settings of the
issues we have described here in order to develop bet-
ten models for addressing medication refusal among
severely mentally ill patients.
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